全球牛市场规模、份额和成长分析：按最终用户和应用分类 - 产业预测（2024-2031）

Global Fetal Bovine Serum Market Size, Share, Growth Analysis, By End-user(Pharmaceutical & Biotechnology Companies, Contract & Academic Research Organizations), By Application(Drug Discovery, In-vitro Fertilization) - Industry Forecast 2024-2031

出版日期: 2024年03月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球牛市场规模将从2023年的17.9亿美元增加至2022年的15.7亿美元，在预测期内（2024-2031年）复合年增长率为14.1%，预计将增长至51.5亿美元到2031年。

全球牛（FBS）市场的主要目标是满足生物医学研究和开发中对优质细胞培养补充品不断增长的需求。有几个因素促进了这个市场的扩张。首先，生物技术和製药领域研发活动投资的增加正在推动对胎牛血清的需求。其次，慢性病的盛行率不断上升以及对有效治疗解决方案的需求需要进行广泛的细胞研究，从而推动了对胎牛血清的需求。然而，全球牛市场正面临各种挑战。关键挑战之一是胎牛血清批次的品质和成分的可变性，这可能会影响研究结果的再现性和可靠性。儘管如此，这个市场仍然存在着成长和创新的机会。作为胎牛血清替代品的无血清培养基和化学成分确定的培养基配方的出现，为市场相关人员提供了满足对不含动物成分的细胞培养解决方案的需求的途径。全球牛市场在支持生物医学研究和细胞培养应用方面发挥着至关重要的作用。儘管面临道德问题、监管限制和品质差异，但市场提供了创新和探索替代解决方案的机会。对细胞研究、再生医学和生技药品的需求不断增长正在推动市场发展，凸显了高品质胎牛血清在科学突破和治疗方法进展中的重要性。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
GE Healthcare（US）
Tissue Culture Biologicals（US）
HiMedia Laboratories Pvt. Ltd.（India）
Atlanta Biologicals Inc.（US）
Sigma-Aldrich Corporation（US）
Rocky Mountain Biologicals（US）
PAN-Biotech GmbH（Germany）
Bovogen Biologicals Pty Ltd.（Australia）
Biowest SAS（France）
Biological Industries Israel Beit Haemek Ltd.（Israel）
Corning Incorporated（US）
Sera Laboratories International Ltd.（UK）
Caisson Laboratories Inc.（US）
Hyclone Laboratories Inc.（US）
Lanzhou Minhai Biotechnology Co., Ltd.（China）
Moregate BioTech（UK）
Gemini Bio-Products（US）
Lampire Biological Laboratories（US）

简介目录

Product Code: SQMIG35I2208

Global Fetal Bovine Serum Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.79 billion in 2023 to USD 5.15 billion by 2031, by rising at a CAGR of 14.1% during the forecast period (2024-2031).

The primary objective of the global fetal bovine serum (FBS) market is to address the rising need for premium-quality cell culture supplements in biomedical research and development. Several factors contribute to the expansion of this market. Firstly, the growing investments in research and development activities across the biotechnology and pharmaceutical sectors drive the demand for FBS. Secondly, the increasing prevalence of chronic diseases and the imperative for effective therapeutic solutions necessitate extensive cell-based research, thereby boosting the demand for FBS. However, the global fetal bovine serum market encounters various challenges. One significant challenge is the variability in the quality and composition of FBS batches, which can impact the reproducibility and reliability of research outcomes. Nonetheless, the market presents opportunities for growth and innovation. The emergence of serum-free and chemically defined media formulations as substitutes to FBS creates avenues for market players to cater to the demand for animal component-free cell culture solutions. The global fetal bovine serum market holds a pivotal role in supporting biomedical research and cell culture applications. Despite facing ethical concerns, regulatory restrictions, and quality variability, the market offers opportunities for innovation and the exploration of alternative solutions. The escalating demand for cell-based research, regenerative medicine, and biologics drives the market, underscoring the significance of high-quality FBS in advancing scientific breakthroughs and therapeutic advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the global fetal bovine serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fetal Bovine Serum Market Segmental Analysis

The global fetal bovine serum market is segmented based on end-user, application, and region. By end-user, the market is segmented into pharmaceutical & biotechnology companies, contract & academic research organizations. By application, the market is segmented into drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Fetal Bovine Serum Market

The biopharmaceutical industry experienced substantial growth, prioritizing the development of innovative therapeutic solutions. Fetal bovine serum (FBS), playing a crucial role in cell culture-based research, saw widespread use in drug discovery, preclinical testing, and biologics production. The heightened investment in biopharmaceutical research and development activities propelled the demand for FBS.

Restraints in the Global Fetal Bovine Serum Market

The utilization of animal-derived products, such as FBS, raised ethical concerns among certain researchers and regulatory bodies. The imperative to minimize or eradicate animal-derived components in cell culture systems prompted the investigation of alternative serum-free and defined media formulations. The presence of these alternatives presented a challenge to the expansion of the FBS market.

Market Trends of the Global Fetal Bovine Serum Market

The industry witnessed a trend towards the creation and adoption of animal component-free culture systems. Researchers and manufacturers aimed to decrease reliance on FBS by transitioning to defined media formulations devoid of animal-derived components. This trend aimed to tackle ethical concerns, improve experimental reproducibility, and streamline regulatory compliance.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Fetal Bovine Serum Market by End-user

Market Overview
Pharmaceutical & Biotechnology Companies
Contract & Academic Research Organizations

Global Fetal Bovine Serum Market by Application

Market Overview
Drug Discovery
In-vitro Fertilization
Vaccine Production
Cell-based Research
Diagnostics
and Others

Global Fetal Bovine Serum Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Culture Biologicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlanta Biologicals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rocky Mountain Biologicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAN-Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bovogen Biologicals Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biowest SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries Israel Beit Haemek Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sera Laboratories International Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caisson Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hyclone Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Minhai Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moregate BioTech (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gemini Bio-Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lampire Biological Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments